Genetic diversity of Mycobacterium tuberculosis isoniazid monoresistant and multidrug-resistant in Rio Grande do Sul, a tuberculosis high-burden state in Brazil

被引:13
|
作者
Esteves, Leonardo Souza [1 ,2 ,5 ]
Dalla Costa, Elis Regina [2 ]
Goncalves Vasconcellos, Sidra Ezidio [4 ]
Vargas, Andrei [2 ]
Montego Ferreira Junior, Sergio Luis [2 ]
Halon, Maria Laura [2 ]
Ribeiro, Marta Osorio [3 ]
Rodenbusch, Rodrigo [2 ]
Gomes, Harrison Magdinier [4 ]
Suffys, Philip N. [4 ]
Rossetti, Maria Lucia R. [1 ,2 ,5 ]
机构
[1] Univ Luterana Brasil ULBRA, Programa Posgrad Biol Mol & Celular Aplicado Saud, 8001 Farroupilha Av, BR-92425900 Canoas, RS, Brazil
[2] Secretaria Estadual Saude CEVS SES RS, Ctr Estadual Vigilancia Saude, 5400 Ipiranga Av, BR-90610000 Porto Alegre, RS, Brazil
[3] Lab Cent Rio Grande do Sul LACEN RS, 5400 Ipiranga Av, BR-90610000 Porto Alegre, RS, Brazil
[4] Inst Oswaldo Cruz IOC FIOCRUZ RJ, Lab Biol Mol Aplicada Micobacterias, 4365 Brasil Av, BR-21040900 Rio De Janeiro, RJ, Brazil
[5] Univ Fed Rio de Janeiro, 550 Pedro Calmon Av, BR-21941901 Rio de Janeiro, RJ, Brazil
关键词
Genotyping; Drug resistance; Tuberculosis; MIRU-VNTR; Brazil; LINE PROBE ASSAY; DRUG-RESISTANCE; RPOB MUTATIONS; TREATMENT OUTCOMES; PULMONARY TUBERCULOSIS; RIFAMPICIN; KATG; STRAINS; IDENTIFICATION; DNA;
D O I
10.1016/j.tube.2018.02.009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Tuberculosis (TB) remains a major public health problem in the world and Brazil is among the countries with the highest incidence and prevalence rates, and Rio Grande do Sul, a Brazilian state, occupy a prominent position. Multidrug-resistant Mycobacterium tuberculosis (MDR-TB) further aggravates this scenario, making it more difficult to treat and control the disease. Isoniazid monoresistance (IMR) may increase the risk of progression to MDR-TB and treatment failure. However, most drug resistance molecular tests only focus on detecting rifampicin (RIF) resistance.In the present study, we characterized a total of 63 drug resistant isolates of M. tuberculosis (35 MDR, 26 IMR and two isolates monoresistant to rifampicin [AMR]) of the Rio Grande do Sul state by MIRU-VNTR (24 loci), spoligotyping, presence of RDRio, fbpdC(103), pks15/1 and sequencing of the katG, rpoB and inhA genes. We observed a higher proportion of the LAM family 30/63 (47.61%). In IMR, mutations were found in the katG gene (98% at codon 315) in 72.5%, and mutations in the promoter region of the inhA gene in 6.25% of the isolates. In MDR-TB and RMR-TB isolates, 92.1% had mutations in the rpoB gene (57% at codon 531). The presence of a 12 bp insertion between codons 516 and 517 of the rpoB gene in MDR-TB isolates was found in five isolates. In conclusion, we observed that the highest frequency of IMR-TB and MDR-TB strains belong to the LAM and Haarlem genotypes in Rio Grande do Sul state. A significant number of isolates previously characterized as Mycobacterium pinnipedi2 through spoligotyping were found to belong to the M. tuberculosis LAM family. This was responsible for a number of significant cases and the molecular profile of this strain and the pattern of mutations related to drug resistance were analyzed. These findings may contribute to a better understanding about the spread of M. tuberculosis resistant in southern of Brazil.
引用
收藏
页码:36 / 43
页数:8
相关论文
共 50 条
  • [21] Spoligotype-Based Comparative Population Structure Analysis of Multidrug-Resistant and Isoniazid-Monoresistant Mycobacterium tuberculosis Complex Clinical Isolates in Poland
    Jagielski, Tomasz
    Augustynowicz-Kopec, Ewa
    Zozio, Thierry
    Rastogi, Nalin
    Zwolska, Zofia
    JOURNAL OF CLINICAL MICROBIOLOGY, 2010, 48 (11) : 3899 - 3909
  • [22] Correlating genetic mutations with isoniazid phenotypic levels of resistance in Mycobacterium tuberculosis isolates from patients with drug-resistant tuberculosis in a high burden setting
    Juliana Maira Watanabe Pinhata
    Angela Pires Brandao
    Flávia de Freitas Mendes
    Michelle Christiane da Silva Rabello
    Lucilaine Ferrazoli
    Rosângela Siqueira de Oliveira
    European Journal of Clinical Microbiology & Infectious Diseases, 2021, 40 : 2551 - 2561
  • [23] Correlating genetic mutations with isoniazid phenotypic levels of resistance in Mycobacterium tuberculosis isolates from patients with drug-resistant tuberculosis in a high burden setting
    Watanabe Pinhata, Juliana Maira
    Brandao, Angela Pires
    Mendes, Flavia de Freitas
    da Silva Rabello, Michelle Christiane
    Ferrazoli, Lucilaine
    de Oliveira, Rosangela Siqueira
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2021, 40 (12) : 2551 - 2561
  • [24] Insight into the drug-resistant characteristics and genetic diversity of multidrug-resistant Mycobacterium tuberculosis in China
    Song, Zexuan
    Liu, Chunfa
    He, Wencong
    Pei, Shaojun
    Liu, Dongxin
    Cao, Xiaolong
    Wang, Yiting
    He, Ping
    Zhao, Bing
    Ou, Xichao
    Xia, Hui
    Wang, Shengfen
    Zhao, Yanlin
    MICROBIOLOGY SPECTRUM, 2023, 11 (05):
  • [25] Improved Outcomes With High-dose Isoniazid in Multidrug-resistant Tuberculosis Treatment in Haiti
    Walsh, Kathleen F.
    Vilbrun, Stalz Charles
    Souroutzidis, Ariadne
    Delva, Sobieskye
    Joissaint, Guy
    Mathurin, Laurent
    Ocheretina, Oksana
    Cremieux, Pierre
    Pape, Jean William
    Koenig, Serena P.
    CLINICAL INFECTIOUS DISEASES, 2019, 69 (04) : 717 - 719
  • [26] GenoType MTBDRplus assay for screening and characterization of isoniazid and rifampicin resistance-associated mutations in multidrug-resistant Mycobacterium tuberculosis from India
    Sethi, S.
    Yadav, R.
    Singh, S.
    Khaneja, R.
    Aggarwal, A.
    Agarwal, P.
    Behera, D.
    LETTERS IN APPLIED MICROBIOLOGY, 2017, 65 (05) : 373 - 380
  • [27] Primary Prison Care Teams and tuberculosis notification in Rio Grande do Sul/Brazil
    Dotta, Renata Maria
    Ely, Karine Zennatti
    Schultz, Aguida Luana Veriato
    Soares Filho, Marden Marques
    Nunes, Pericles Stehmann
    Busatto, Caroline
    Possuelo, Lia Goncalves
    CIENCIA & SAUDE COLETIVA, 2022, 27 (12): : 4415 - 4422
  • [28] First genetic characterisation of multidrug-resistant Mycobacterium tuberculosis isolates from Algeria
    Bouziane, Feriel
    Allem, Rachida
    Sebaihia, Mohammed
    Kumanski, Sylvain
    Mougari, Faiza
    Sougakoff, Wladimir
    Raskine, Laurent
    Yala, Djamel
    Cambau, Emmanuelle
    Aubry, Alexandra
    Bonnet, Isabelle
    Benmansour, Hana
    Jaffre, Jeremy
    Jarlier, Vincent
    Lecorche, Emmanuel
    Morel, Florence
    Robert, Jerome
    Veziris, Nicolas
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2019, 19 : 301 - 307
  • [29] Strain diversity and gene mutations associated with presumptive multidrug-resistant Mycobacterium tuberculosis complex isolates in Northwest Ethiopia
    Ejo, Mebrat
    Torrea, Gabriela
    Diro, Ermias
    Abebe, Ayenesh
    Kassa, Meseret
    Girma, Yilak
    Tesfa, Eyasu
    Ejigu, Kefialew
    Uwizeye, Cecile
    Gehre, Florian
    de Jong, Bouke C.
    Rigouts, Leen
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2023, 32 : 167 - 175
  • [30] Genetic diversity of multidrug-resistant Mycobacterium tuberculosis strains isolated from tuberculosis patients in Iran using MIRU-VNTR technique
    Khosravi, Azar Dokht
    Shahraki, Abdolrazagh Hashemi
    Dezfuli, Soolmaz Khandan
    Hashemzadeh, Mohammad
    Goodarzi, Hamed
    Mohajeri, Parviz
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2017, 33 (11) : 550 - 557